1. Wp 4: Stimulating the environment for a wider economic exploitation and job creation

2. Who are we? Jean-Pierre Saintouil Director of the Technology Transfer Service at the Pasteur Institute, Paris Jonathan Weitzman Technology Transfer Officer at the Pasteur Institute, Paris Kathleen Victoir Scientific Officer for the Pathogenomics network

3. What are our objectives? Development of novel instruments to support public-private partnerships

4. 1.Organise a « web-based innovation market » 2.Organise and support a network of technology transfer and/or innovation agencies. 3.….

5. € INDUSTRY

6. How will we proceed? 1. Establish a list of key-contact persons concerning Pathogenomic related technology transfer 2. Organise a first « kick-off » meeting with PathoGenomics Innovation Partners (first PIP- meeting, end of November 2005, Paris)

7. 3.Writing of a Strategy Paper, which will be diffused to an enlarged network and integration of feed-back. 4. Discussion with a) Industry and b) scientists (wp3), and integration of comments in Strategy Paper

8. 5. SMEs/industry meeting on IPR and innovation issues (FEMS meeting in July 2006 Madrid?) 6. Web-market place for innovations (guidelines for input and use) (link with central resource centre wp3?) 7. Follow-up of the PIP-network

9. « Kick-Off » meeting, Pasteur Institute, Paris -One Technology Transfer representative/country -Specificities of each technology transfer situation (country, institution, university,….) -Identify the gaps in the existing Technology Transfer chain

10. -Put them into the context of « Pathogenomics » e.g. * How did the « –omics » change the tech world and what are the specific problems? * What are the market specificities, (scientists, society)?

11. Entrepreneurship Promotion IPR and patenting Liaison for contract research Support to spin offs Structural support Incubators Science and technology parks Innovation relay centers Business innovation centres Commercialisation and valorisation of technology (private sector) Knowledge and technology generation (laboratories at universities, research institutes)

12. Application Invention Communication between scientist/tto Communication between tto/industry Maturation of the invention IPR

13. needs (patients, scientists) identified Market social pressure Interest of Industry/SMEs Therapy Diagnosis Prophylactic treatment High troughput technology Testing of appropriate models

14. Thank you